Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
- 2021-05-29
- Nutrients 13(6)
- PubMed: 34072532
- DOI: 10.3390/nu13061860
Study Design
- Population
- Colitic mice
- Methods
- In vitro and in vivo experimental study
Abstract
Limosilactobacillus reuteri INIA P572 is a strain able to produce the antimicrobial compound reuterin in dairy products, exhibiting a protective effect against some food-borne pathogens. In this study, we investigated some probiotic properties of this strain such as resistance to gastrointestinal passage or to colonic conditions, reuterin production in a colonic environment, and immunomodulatory activity, using different in vitro and in vivo models. The results showed a high resistance of this strain to gastrointestinal conditions, as well as capacity to grow and produce reuterin in a human colonic model. Although the in vitro assays using the RAW 264.7 macrophage cell line did not demonstrate direct immunomodulatory properties, the in vivo assays using a Dextran Sulphate Sodium (DSS)-induced colitic mice model showed clear immunomodulatory and protective effects of this strain.
Keywords: DSS-induced colitic model; Limosilactobacillus reuteri; colonic model; immunomodulation; probiotic; protective effect; reuterin.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|